搜索筛选:
搜索耗时2.6272秒,为你在为你在102,285,761篇论文里面共找到 5 篇相符的论文内容
发布年度:
[期刊论文] 作者:Domenico Germano,Bruno Daniele,,
来源:World Journal of Gastroenterology 年份:2014
The management of hepatocellular carcinoma(HCC)has substantially changed in the past few decades,the introduction of novel therapies(such as sorafenib)have impr...
,TIE2-expressing monocytes as a diagnostic marker for hepatocellular carcinoma correlates with angio
[期刊论文] 作者:Domenico Germano,Bruno Daniele,
来源:肝胆外科与营养 年份:2014
Hepatocellular carcinoma (HCC) is the third most common cause of cancer-related deaths worldwide. In the past few years, the mechanisms of hepato-carcinogenesis...
[期刊论文] 作者:Massimo Di Maio,Bruno Daniele,,
来源:世界胃肠病学杂志:英文版(电子版) 年份:2008
在最近获得与的阳性结果前多指向酷氨酸激酶禁止者 sorafenib,为有先进肝细胞癌(HCC ) 的病人没有标准全身的治疗。性别荷尔蒙受体在 HCC 样品的一个重要比例被表示。支持在性...
[期刊论文] 作者:Massimo Di Maio,Bruno Daniele,Sandro Pignata,Ciro Gallo,Ermelinda De Maio,Alessandro Morabito,Maria Carmela,
来源:World Journal of Gastroenterology 年份:2008
Before the positive results recently obtained with multitarget tyrosine kinase inhibitor sorafenib,there was no standard systemic treatment for patients with ad...
[期刊论文] 作者:Massimo Di Maio,Bruno Daniele,Sandra Pignata,Ciro Gallo,Ermelinda De Maio,Alessandro Morabito,Maria Carmela,
来源:世界胃肠病学杂志(英文版) 年份:2008
Before the positive results recently obtained with multitarget tyrosine kinase inhibitor sorafenib, there was no standard systemic treatment for patients with a...
相关搜索: